Risks include mild side effects and rare but serious complications
Skip to main content About About SGC Members & Technology Partners Governance Open Science Impact SGC Gender Equality Plan SGC Sites & People Global SGC Toronto SGC UNC SGC Karolinska SGC Frankfurt SGC Neuro SGC UCL SGC Unicamp Science and Resources Proteins Structure Gallery Protein Production Resources Expression Vectors Constructs Legacy Protein Protocols Chemistry Chemical Probes SGC Chemical Probes Donated Chemical Probes Chemical Handles Chemogenomic Sets Open Data Target Enabling Packages Patient Tissue Platform Open Lab Notebooks Publications Bioinformatics Resources ChemBioPort UbiHub ChromoHub Initiatives Overview Target 2035 Protein Contribution Network AIRCHECK MAINFRAME CACHE Conscience Agora Open Science Trust EUbOPEN Open Chemistry Networks Womens and Childrens Health Initiative READDI AViDD TREAT AD YCharOS News & Outreach News from SGC Press Releases Blogs Get Involved Participate Donate Careers Contact Us Donate Home About About SGC Members & Technology Partners Governance Open Science Impact SGC Gender Equality Plan SGC Sites & People Global SGC Toronto SGC UNC SGC Karolinska SGC Frankfurt SGC Neuro SGC UCL SGC Unicamp Science and Resources Proteins Structure Gallery Protein Production Resources Expression Vectors Constructs Legacy Protein Protocols Chemistry Chemical Probes SGC Chemical Probes Donated Chemical Probes Chemical Handles Chemogenomic Sets Open Data Target Enabling Packages Patient Tissue Platform Open Lab Notebooks Publications Bioinformatics Resources ChemBioPort UbiHub ChromoHub Initiatives Overview Target 2035 Protein Contribution Network AIRCHECK MAINFRAME CACHE Conscience Agora Open Science Trust EUbOPEN Open Chemistry Networks Womens and Childrens Health Initiative READDI AViDD TREAT AD YCharOS News & Outreach News from SGC Press Releases Blogs Get Involved Participate Donate Careers Contact Us Donate Search Crystal structure of human glutathione peroxidase 5 Protein: GPX5 PDB ID: 2I3Y Deposition Date: Monday 21st August 2006 Authors: Kavanagh, K.L., Johansson, C., Rojkova, A., Umeano, C., Bunkoczi, G., Gileadi, O., von Delft, F., Weigelt, J., Arrowsmith, C., Sundstrom, M., Edwards, A., Oppermann, U.
166, 495499 [DOI] [PMC free article] [PubMed] [Google Scholar] Ando K., Kikugawa K., Beppu M
Lin HY, Tang HY, Keating T, Wu YH, Shih A, Hammond D, et al
Choosing the Best Glutathione Injectable Plan: 3-Month, 6-Month, and 12-Month Protocols The 3-Month Foundation Protocol: Establishing Baseline Benefits The initial three-month injectable glutathione protocol serves as the foundation phase for individuals new to glutathione therapy
Vasopressin injection prescribing information
